Takeda Pharmaceutical (4502 JP): Strong Q3 Result Triggers Guidance Raise; ¥100B Buyback Announced
Takeda has upgraded its full year outlook for growth, reflecting strong year-to-date product performance and OPEX efficiencies, and revised Fx...
515 Views
Pre-IPO Ascentage Pharma - The US Stock Listing Will Stimulate Future Growth Potential
Ascentage aims to raise $100 million in US IPO, with potential valuation surpassing Hutchmed. Olverembatinib's outlook is certain. Catalyst is...
1.2k Views
Additional Points Add to Our Recent Bearish View on Takeda.
Additional points add to our recent bearish view on Takeda. We are particularly concerned about the psoriasis acquisition and restructuring.
617 Views
Takeda Sells Japan OTC Business to Blackstone; Last of Its Non-Core Asset Sales to Raise US$10bn
Takeda announced on Monday (24th August 2020) that it has entered into an agreement to sell its domestic consumer health business (known as Takeda...
460 Views
TOPIX Inclusion (9273 JP): Koa Shoji Holdings
Koa Shoji Holdings (9273 JP) confirmed (J-only) on 15th June they had received approval to move from the Second Section to the First Section of...
596 Views